Probing mechanisms and improving management of glaucoma following Boston keratoprosthesis surgery. Issue 2 (16th February 2023)

• Record Type: Journal Article
• Authors: Geoffrion, Dominique; Koenekoop, Robert K.; Harissi‐Dagher, Mona
• Is Part Of: Acta ophthalmologica. Volume 101:Issue 2(2023)
• Page Start: 242
• Page End: 243
• Publication Date: 2023-02-16
• Subjects: Ophthalmology -- Periodicals; 617.7005
• DOI: 10.1111/aos.15297
• Languages: English
• ISSNs: 1755-375X

Abstract

Abstract: Corneal blindness is a leading cause of visual impairment worldwide. The most common treatment is to replace the diseased cornea with standard corneal transplantation. In eyes at high risk of graft failure, the Boston keratoprosthesis type 1 (KPro) can be used to restore vision and is currently the most frequently used artificial cornea in the world. However, glaucoma is a well‐known complication of KPro surgery and is the most important threat to vision in KPro‐implanted eyes. This chronic disease is influenced by elevated intraocular pressure (IOP) and damages the optic nerve, leading to progressive vision loss. In KPro patients, glaucoma is highly prevalent and extremely challenging to manage, yet its exact cause remains unknown.